NewsRx

Search our medical news database

Cervical Cancer - Risk Factors

Persistence of HPV Infection is Predictive of Persistent Dysplasia

Published in Women's Health Weekly, September 25th, 1995

The persistence of human papillomavirus (HPV) infection provides an additional diagnostic tool for determining a woman's likelihood of progressing to cervical cancer versus one who's lesions might spontaneously regress.

Cytologically referred to as squamous intraepithelial lesion (SIL) or histopathologically referred to as cervical intraepithelial neoplasia (CIN), cervical dysplasia is thought to progress in stages to cervical cancer. The majority of mild lesions (CIN stage I) tend to regress spontaneously. Etiological factors for the progression, rather than the regression, of these lesions to cervical cancer is not fully understood.

Gloria Y.F....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook